Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism BCL10 inhibitors(BCL10 immune signaling adaptor inhibitors), MALT1 inhibitors(Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis | Discovery | - | 29 Sep 2022 | |
Colitis | Discovery | - | 29 Sep 2022 | |
Crouzon Syndrome With Acanthosis Nigricans | Discovery | - | 29 Sep 2022 | |
Crouzon Syndrome With Acanthosis Nigricans | Discovery | - | 29 Sep 2022 | |
Immune System Diseases | Discovery | - | 29 Sep 2022 | |
Immune System Diseases | Discovery | - | 29 Sep 2022 | |
Neoplasms | Discovery | - | 29 Sep 2022 | |
Neoplasms | Discovery | - | 29 Sep 2022 |